Apr 27, 2023 AURORA, Colo., April 27, 2023 /PRNewswire/ -- Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection
Molecular Designs releases their new Simplicity™ Gastrointestinal Pathogen Panel
Apr 11, 2023 BIRMINGHAM, Ala., April 11, 2023 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease
Foresight Diagnostics & leading cancer center to present solid tumor MRD data at AACR conference
Apr 04, 2023 AURORA, Colo., April 4, 2023 /PRNewswire/ -- Foresight Diagnostics, a leader in molecular cancer diagnostics, announced the
Factorial Biotechnologies collaborates with Watchmaker Genomics to dramatically simplify single-cell sequencing
Mar 28, 2023 SAN CARLOS, Calif., March 28, 2023 /PRNewswire/ -- Factorial Biotechnologies, an emerging single-cell sequencing company with a
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Aug 31, 2022 Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace
YDS Pharmatech helps uncover a novel viral recognition pathway: published in Nature Chemical Biology
Aug 18, 2022 YDS Pharmatech announced the publication of a paper revealing a novel human viral recognition mechanism in Nature Chemical Biology
A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports
Jun 14, 2022 Flagship Biosciences, Inc., today announced the publication of a paper describing validation of a novel digital spatial biology
DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus
Jun 09, 2022 DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE
DxTerity Diagnostics Begins Enrollment in the ELEVATE Clinical Study for Lupus
May 27, 2022 LOS ANGELES, May 27, 2022 /PRNewswire/ -- DxTerity Diagnostics today announced the opening of enrollment in ELEVATE